Neurorehabilitation Devices Market Report 2026

Neurorehabilitation Devices Market Overview

• Neurorehabilitation Devices market size has reached to $2.07 billion in 2025 • Expected to grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.5% • Growth Driver: Neurological Diseases Propel Growth Of The Neurorehabilitation Devices Market • Market Trend: Revolutionary Hyper-Sensitive Controller Enhances Neurorehabilitation For Motor Function • North America was the largest region in 2025.

What Is Covered Under Neurorehabilitation Devices Market?

Neurorehabilitation devices refer to specialized tools and equipment designed to assist in the rehabilitation of individuals with neurological disorders or injuries. These devices aim to restore or improve functions that have been impaired due to conditions such as stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, or other neurological diseases. The main products of neurorehabilitation devices are brain-computer interfaces, wearable devices, non-invasive stimulators, and others. A brain-computer interface (BCI) refers to a technology that enables direct communication between the brain and an external device, often bypassing traditional pathways such as muscles or nerves. It has various applications, including treatment for stroke, Parkinson’s disease, brain and spinal cord injuries, cerebral palsy, multiple sclerosis, and more. The end users of these devices include rehabilitation centers, hospitals and clinics, home care settings, and others.

What Is The Neurorehabilitation Devices Market Growth Forecast?

The neurorehabilitation devices market size is expected to see rapid growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to aging population growth, demand for home care rehabilitation, technological innovation in exoskeletons, rising neurological injury cases, increased healthcare funding. Major trends in the forecast period include growing adoption of robotic rehabilitation systems, rising use of wearable neurorehabilitation devices, expansion of home-based rehabilitation programs, increased focus on personalized therapy plans, integration of cognitive and physical rehabilitation.

Global Neurorehabilitation Devices Market Segmentation

1) By Product: Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Other Products 2) By Application: Stroke, Parkinson's Disease, Brain And Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Other Applications 3) By End User: Rehabilitation Centers, Hospitals And Clinics, Home Care, Other End Users Subsegments: 1) By Neurorobotics: Robotic Exoskeletons, Robotic Rehabilitation Devices, Assistive Robots For Gait Training 2) By Brain-Computer Interface: Invasive Brain-Computer Interfaces, Non-Invasive Brain-Computer Interfaces, Hybrid Brain-Computer Interfaces 3) By Wearable Devices: Smart Gloves, Smart Sensors, Exosuits and Wearable Robotics 4) By Non-Invasive Stimulators: Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Functional Electrical Stimulation (FES) Devices 5) By Other Products: Virtual Reality Rehabilitation Systems, Software Platforms For Neurorehabilitation, Cognitive Training Devices

What Is The Driver Of The Neurorehabilitation Devices Market?

The increasing prevalence of neurological diseases is expected to propel the growth of the neurorehabilitation devices market going forward. The rising cases of neurological diseases are rising due to several reasons, including an aging population, improved diagnostics, increased awareness, and stress and mental health. Neurorehabilitation devices are utilized for neurological diseases by aiding in the restoration of motor, cognitive, and sensory functions through targeted therapies and stimulation. For instance, in May 2025, according to the Headway, a UK-based non-profit organization, in the UK, 335,409 people were admitted to hospitals in 2023–2024 due to acquired brain injury (ABI). Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurorehabilitation devices industry.

Key Players In The Global Neurorehabilitation Devices Market

Major companies operating in the neurorehabilitation devices market are ReWalk Robotics Ltd., Ottobock SE & Co. KGaA, Helius Medical Technologies Inc., Bioness Inc., Neofect Co. Ltd., Tyromotion GmbH, Ekso Bionics Holdings Inc., Reha Technology AG, Kinestica Inc., Motus Nova, NeuroGym, NeuroMetrix Inc., Rehab‑Robotics Company Limited, Rex Bionics Ltd., Saebo Inc., Bionik Laboratories Corp., Medtronic plc, Abbott Laboratories, Hocoma AG, Cyberdyne Inc., MindMaze SA, NeuroPace Inc., Paradromics Inc., Cognixion

Global Neurorehabilitation Devices Market Trends and Insights

Major companies operating in the neurorehabilitation devices market are focusing on developing innovative products, such as hyper-sensitive controllers to enhance precision and patient interaction during rehabilitation therapies. A hyper-sensitive controller refers to a component or system designed to respond with high sensitivity to a user's movements, intentions, or neural signals. For instance, in February 2023, MindMaze, a Switzerland-based digital neurotherapeutics (DTx) solutions company, launched Izar, an innovative smart peripheral device designed to enhance hand motor function in patients with neurological conditions such as stroke and Parkinson's disease. This advanced, portable device improves hand dexterity and strength by accurately detecting fine grasp forces and wrist movements, allowing for precise training and assessment. Izar supports both in-clinic and remote self-training, addressing a critical need in neurological rehabilitation.

What Are Latest Mergers And Acquisitions In The Neurorehabilitation Devices Market?

In August 2023, ReWalk Robotics Ltd., an Israel-based medical device company, acquired AlterG for $19 million. The acquisition seeks to expand ReWalk's product portfolio and enhance its position in the rehabilitation and mobility sector by integrating AlterG's anti-gravity treadmill technology with its existing exoskeleton products. AlterG is a US-based provider of anti-gravity systems for use in physical and neurological rehabilitation.

Regional Outlook

North America was the largest region in the neurorehabilitation devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neurorehabilitation Devices Market?

The neurorehabilitation devices market consists of sales of robotic exoskeletons, neuroprosthetics, brain-computer interfaces (BCI), functional electrical stimulation (FES) devices, transcranial magnetic stimulation (TMS) devices, virtual reality (VR), and rehabilitation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.